Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Fuji
Cerilliant
Farmers Insurance
Express Scripts
Argus Health
Queensland Health
Merck
Cipla
Boehringer Ingelheim

Generated: February 19, 2018

DrugPatentWatch Database Preview

NIMOTOP Drug Profile

« Back to Dashboard

When do Nimotop patents expire, and what generic alternatives are available?

Nimotop is a drug marketed by Bayer Pharms and is included in one NDA.

The generic ingredient in NIMOTOP is nimodipine. There are seven drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the nimodipine profile page.
Summary for NIMOTOP
Drug patent expirations by year for NIMOTOP
Medical Subject Heading (MeSH) Categories for NIMOTOP

US Patents and Regulatory Information for NIMOTOP

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Pharms NIMOTOP nimodipine CAPSULE;ORAL 018869-001 Dec 28, 1988 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for NIMOTOP

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bayer Pharms NIMOTOP nimodipine CAPSULE;ORAL 018869-001 Dec 28, 1988 ➤ Sign Up ➤ Sign Up
Bayer Pharms NIMOTOP nimodipine CAPSULE;ORAL 018869-001 Dec 28, 1988 ➤ Sign Up ➤ Sign Up
Bayer Pharms NIMOTOP nimodipine CAPSULE;ORAL 018869-001 Dec 28, 1988 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Cipla
AstraZeneca
US Department of Justice
Deloitte
Chubb
UBS
Johnson and Johnson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot